Reduced expression of calponin h1 in leiomyosarcoma of the uterus

Laboratory Investigation

Volumn 78, Issue 7, 1998, Pages 839-846

  Horiuchi, Akiko ^a   Nikaido, Toshio ^a   Ito, Kazuko ^a   Zhai, Ya Li ^a   Orii, Ayaka ^a   Taniguchi, Shunichiro ^a   Toki, Toshihiko ^a   Fujii, Shingo ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALPONIN; CYTOSKELETON PROTEIN; DNA; RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MUSCLE TUMOR; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS MYOMA; UTERUS SARCOMA;

ADULT; AGED; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MICROFILAMENT PROTEINS; MIDDLE AGED; MYOMETRIUM; POLYMERASE CHAIN REACTION; PROGNOSIS; TIME FACTORS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0031871390     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Amada S, Nakano H, and Tsuneyoshi M (1995). Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: A comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 14: 134-142.
2. Bell SW, Kempson RL, and Hendrickson MR (1994). Problematic uterine smooth muscle neoplasms. Am J Surg Pathol 18:535-558.
3. Bird A (1992). The essentials of DNA methylation. Cell 70: 5-8.
4. Boehncke WH, Schwenck K, Sterry W, and Kaufmann R (1994). Primary subcutaneous leiomyosarcoma exhibiting the characteristic immunophenotype positive for vimentin and desmin. J Dermatol Surg Oncol 20:541-543.
5. Chamley-Campbell J, Campbell GR, and Ross R (1979). The smooth muscle cell in culture. Physiol Rev 59:1-61.
6. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
7. Fayed YM, Tsibris JC, Langenberg PW, and Robertson AL Jr (1989). Human uterine leiomyoma cells: Binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab Invest 60:30-37.
8. Fogh J and Trempe G (1975). In: Fogh J, editor: Human tumor cells in vitro. New York: Plenum Press.
9. Gimona M, Herzog M, Vandekerckhove J, and Small JV (1990). Smooth muscle specific expression of calponin. FEBS Lett 274:159-162.
10. Hendrickson MR and Kempson RL (1995). Pure mesenchymal neoplasms of the uterine corpus. In: Fox H, Wells M, editors: Obstetrical and gynecological pathology, 4th ed, vol 1. Edinburgh: Churchill Livingstone, 542-573.
11. Ishiwata I, Nozawa S, Nagai S, Kurihara S, Mikata A, and Okumura H (1977). Establishment of a human leiomyosarcoma cell line. Cancer Res 37:658-664.
12. Koutsilieris M, Elimeliani D, Frenette G, and Maheux R (1992). Leiomyoma-derived growth factors for smooth muscle cells. In Vivo 6:579-85.
13. Koutsilieris M, Michaud J, and Nikolis A (1990). Preferential mitogenic activity for myoblast-like cells can be extracted from uterine leiomyoma tissues. Am J Obstet Gynecol 163: 1665-1670.
14. Kumar CC, Kim JH, Bushel LP, Armstrong L, and Catino JJ (1995). Activation of smooth muscle α-actin promoter in ras-transformed cells by treatments with antimitotic agents: Correlation with stimulation of SRF-SRE mediated gene transcription. J Biochem 118:1285-1292.
15. Kuramoto H, Tamura S, and Notake Y (1972). Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol 114:1012-1019.
16. Leavitt J, Gunning P, Kedes L, and Jariwalla R (1985). Smooth muscle alpha-actin is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cells. Nature 316:840-842.
17. Maguchi M, Nishida W, Kohara K, Kuwano A, Kondo I, and Hiwada K (1995). Molecular cloning and gene mapping of human basic and acidic calponins. Biochem Biophys Res Commun 217:238-244.
18. McHugh KM (1995). Molecular analysis of smooth muscle development in the mouse. Dev Dyn 204:278-90.
19. McHugh KM (1996). Molecular analysis of gastrointestinal smooth muscle development. J Pediatr Gastroenterol Nutr 23:379-94.
20. Miano JM and Olson EN (1996). Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem 271:7095-7103.
21. Negoro N, Fukui R, Tsuchikane E, Otsuji S, Kato O, Kobayashi T, Tkagi M, Eshita Y, Nishida M, Kojima A, Takahashi K, and Shibata N (1994). Down-expression of calponin in smooth muscle of coronary artery lesions identifies a group of lesions at high risk for restenosis after atherectomy: Implications for human gene therapy by direct calponin gene transfer. Circulation 90:1-142.
22. Razin A and Kafri T (1994). DNA methylation from embryo to adult. Prog Nucleic Acid Res 48:53-81.
23. Rein MS, Friedman AJ, Pandian MR, and Heffner LJ (1990). The secretion of insulin- like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist. Obstet Gynecol 76:388-94.
24. Samaha FF, Ip HS, Morrisey EE, Seltzer J, Tang Z, Solway J, and Parmacek MS (1996). Developmental pattern of expression and genomic organization of the calponin-h1 gene: A contractile smooth muscle cell marker. J Biol Chem 271:395-403.
25. Schurch W, Skalli O, Seemayer TA, and Gabbiani G (1987). Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. Am J Pathol 128:91-103.
26. Skalli O, Vandekerckhove J, and Gabbiani G (1987). Actin-isoform pattern as a marker of normal or pathological smooth-muscle and fibroblastic tissues. Differentiation 33: 232-238.
27. Sourla A and Koutsilieris M (1995). Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts. J Clin Invest 96:751-758.
28. Sprogoe-Jakobsen S and Holund B (1996). Immunohistochemistry (ki67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus). APMIS 104:705-708.
29. Strasser P, Gimona M, Moessler H, Herzog M, and Small JV (1993). Mammalian calponin: Identification and expression of genetic variants. FEBS Lett 330:13-18.
30. Takahashi K, Hiwada K, and Kokubu T (1986). Isolation and characterization of a 34000-dalton calmodulin- and F-actin-binding protein from chicken gizzard smooth muscle. Biochem Biophys Res Commun 141:20-26.
31. Takahashi K, Hiwada K, and Kokubu T (1988). Vascular smooth muscle calponin: A novel troponin T-like protein. Hypertension 11:620-626.
32. Takahashi K, Miwa A, Tkagi M, Kojima A, Eshita Y, Nara Y, Yamori Y, Hirabayashi M, Kato O, Awata TN, Kobayashi T, and Shibata N (1995). Overexpression of calponin in transgenic rats inhibits intimai arterial smooth muscle cell hyperplasia in the carotid artery model of restenosis. Circulation 92:1-295.
33. Takahashi K and Nadal-Ginard B (1991). Molecular cloning and sequence analysis of smooth muscle calponin. J Biol Chem 266:13284-13288.
34. Takahashi K, Tazunoki T, Okada T, Ohgami K, Miwa T, Miki A, and Shibata N (1996). The 5′-flanking region of the human smooth muscle cell calponin gene contains a cis-acting domain for interaction with a methylated DNA-binding transcription repressor. J Biochem 120:18-21.
35. Takahashi K, Tkagi M, Ohgami K, Nakai M, Kojima A, Nadal-Ginard B, and Shibata N (1993). Inhibition of smooth muscle cell migration and proliferation caused by transfection of the human calponin gene is associated with enhanced cell matrix adhesion and reduced PDGF responsiveness. Circulation 88:1-174.
36. Taylor HB and Norris HJ (1966). Mesenchymal tumors of the uterus: IV - Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 82:40-44.
37. Trzyna W, McHugh M, McCue P, and McHugh KM (1997). Molecular determination of the malignant potential of smooth muscle neoplasms. Cancer 80:211-217.
38. Van der Ven LT, Gloudemans T, Roholl PJ, van Buul-Offers SC, Bladergroen BA, Welters MJ, Sussenbach JS, and den Otter W (1994). Growth advantage of human leiomyoma cells compared to normal smooth muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer 59:427-434.
39. Vollenhoven BJ, Herington AC, and Healy DL (1993). Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab 76:1106-1110.
40. Zaloudek C and Norris HJ (1994). Mesenchymal tumors of the uterus. In: Kurman RJ, editor: Blaustein's pathology of the female genital tract, 4th ed. New York: Springer-Verlag, 849-914.